MIRA PHARMACEUTICALS, INC.
Pharmaceutical Preparations · MIAMI · FL
Moderate confidence (50%)
Updated Oct 19, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: MIRA PHARMACEUTICALS, INC. received a delisting notice from its exchange (Jul 27, 2026)
Timeline
Every material event, newest first. History is never overwritten.
MIRA PHARMACEUTICALS, INC. received a delisting notice from its exchange
Jul 27, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 27, 2026, Mira Pharmaceuticals, Inc. (the Company ) received a letter (the Letter ) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that, based upon the closing bid price of the Company s common stock ( Common Stock ) for the 30 consecutive business days ended July 24, 2026, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker MIRA on Nasdaq.
- SEC CIK
- 0001904286
- Website
- —
- —
- Headquarters
- MIAMI, FL
- Also known as
- Mira1a Therapeutics, Inc.
- Legal entities
- MIRA PHARMACEUTICALS, INC.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
MIRA PHARMACEUTICALS, INC. — Pharmaceutical Preparations (SIC 2834) — MIAMI, FL
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 27, 2026, Mira Pharmaceuticals, Inc. (the Company ) received a letter (the Letter ) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ( Nasdaq ) indicating that, based upon the closing bid price of the Company s common stock ( Common Stock ) for the 30 consecutive business days ended July 24, 2026, the Company no longer meets the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:27 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.